Oncologix Tech, Inc. Share Price Other OTC
Equities
OCLG
US68230M2098
Investment Holding Companies
Sales 2013 | 0.24 20.36 | Sales 2014 | 3.68 306.54 | Capitalization | 758K 63.18M |
---|---|---|---|---|---|
Net income 2013 | - 0 | Net income 2014 | -1M -83.36M | EV / Sales 2013 | 87,16,069 x |
Net Debt 2013 | 1.33M 111M | Net Debt 2014 | 1.89M 158M | EV / Sales 2014 | 7,21,342 x |
P/E ratio 2013 |
-1.03
x | P/E ratio 2014 |
-0.47
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
Nikole Jessie
IRO | Public Communications Contact | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 25/21/25 |
1st Jan change | Capi. | |
---|---|---|
+173.89% | 6.65B | |
+2.29% | 981M | |
+5.57% | 928M | |
+41.91% | 872M | |
+20.36% | 804M | |
+1.72% | 664M | |
-.--% | 600M | |
-2.15% | 593M | |
+40.25% | 552M |